Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Long-Term Investments: 2024-2025

  • CorMedix's Long-Term Investments was N/A to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year change of. This contributed to the annual value of $105,368 for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Long-Term Investments stood at $22.9 million for Q3 2025, which was up 21,646.41% from $105,368 recorded in Q4 2024.
  • CorMedix's 5-year Long-Term Investments high stood at $22.9 million for Q3 2025, and its period low was $105,368 during Q4 2024.
  • Moreover, its 2-year median value for Long-Term Investments was $11.5 million (2024), whereas its average is $11.5 million.